Amniotics AB (OSTO:AMNI) Additional Paid-In Capital : kr100.08 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Additional Paid-In Capital?

Amniotics AB's quarterly additional paid-in capital stayed the same from Jun. 2023 (kr76.31 Mil) to Sep. 2023 (kr76.31 Mil) but then increased from Sep. 2023 (kr76.31 Mil) to Dec. 2023 (kr100.08 Mil).

Amniotics AB's annual additional paid-in capital stayed the same from Dec. 2021 (kr60.79 Mil) to Dec. 2022 (kr60.79 Mil) but then increased from Dec. 2022 (kr60.79 Mil) to Dec. 2023 (kr100.08 Mil).

Amniotics AB Additional Paid-In Capital Historical Data

The historical data trend for Amniotics AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Additional Paid-In Capital Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

20.13

90.55

60.79

100.08

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial										-	60.79	76.31	76.31	100.08

Amniotics AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Amniotics AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.